Evaluation of Novel Antimicrobial Hand Towels

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02512614

Enrollment

449

Registered

2015-07-31

Start date

2012-03-31

Completion date

2013-04-30

Last updated

2015-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Infections, Diarrheal Diseases, Fever, Skin Infection

Brief summary

In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9. The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections, self-reported fever, and skin infections in children \<2 years old.

Detailed description

In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9. The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections (ARIs), self-reported fever, and skin infections in children \<2 years old.

Interventions

OTHERAntimicrobial Hand Towel

Novel antimicrobial hand towel.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* Mother of a child \<2 years old

Exclusion criteria

* Inaccessible enumeration area in the rainy season * Multiple eligible children in a single compound * Moved between census and round 1

Design outcomes

Primary

Measure	Time frame	Description
Number of participants with diarrheal disease	Within 48 hours of enrollment	The number of participants that experience 3 or more loose or watery stools

Secondary

Measure	Time frame
Number of participants with respiratory infections	Within 48 hours of enrollment
Number of participants with a subjective fever	Within 48 hours of enrollment
Number of participants with a skin infection	Within 48 hours of enrollment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026